Ro 27-3225
| Drug Information | |||
|---|---|---|---|
| Image | |||
| Identifiers
CAS Number ATC Code PubChem DrugBank ChemSpider ID UNII KEGG ChEBI ChEMBL IUPAC Name |
Chemical Data
C H N O Molecular Weight | ||
Ro 27-3225 is a chemical compound that has been studied for its potential effects on the melanocortin receptor system. It is primarily known as a selective agonist for the melanocortin 4 receptor (MC4R), which is involved in the regulation of energy homeostasis, sexual function, and other physiological processes.
Pharmacology[edit | edit source]
Ro 27-3225 acts as a selective agonist at the MC4R, which is a G protein-coupled receptor (GPCR) that plays a crucial role in the regulation of appetite and energy balance. Activation of MC4R by Ro 27-3225 has been shown to influence feeding behavior and energy expenditure in animal models.
Mechanism of Action[edit | edit source]
The mechanism of action of Ro 27-3225 involves binding to the MC4R, leading to the activation of intracellular signaling pathways. This activation results in the modulation of neuronal circuits that control appetite and energy expenditure. The MC4R is expressed in various regions of the brain, including the hypothalamus, which is a key area for the regulation of hunger and satiety.
Therapeutic Potential[edit | edit source]
Due to its role in modulating energy balance, Ro 27-3225 has been investigated for its potential use in treating conditions such as obesity and metabolic syndrome. By activating the MC4R, Ro 27-3225 may help reduce food intake and increase energy expenditure, contributing to weight loss and improved metabolic health.
Research and Development[edit | edit source]
Research on Ro 27-3225 has primarily been conducted in preclinical settings, using animal models to assess its efficacy and safety. Studies have demonstrated that Ro 27-3225 can reduce food intake and body weight in rodents, suggesting its potential as an anti-obesity agent. However, further research is needed to evaluate its effects in humans and to determine its safety profile.
Side Effects and Safety[edit | edit source]
As with any pharmacological agent, the use of Ro 27-3225 may be associated with side effects. In animal studies, potential side effects have included changes in blood pressure and heart rate, which are consistent with the activation of the MC4R. The safety and tolerability of Ro 27-3225 in humans remain to be fully established through clinical trials.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
